RT @CIR_AACR: Depleting #Tregs with an #ICOS-specific antibody increases #Tcell function, delays tumor growth, and improves efficacy of #Im…
RT @CIR_AACR: Depleting #Tregs with an #ICOS-specific antibody increases #Tcell function, delays tumor growth, and improves efficacy of #Im…
RT @CIR_AACR: Depleting #Tregs with an #ICOS-specific antibody increases #Tcell function, delays tumor growth, and improves efficacy of #Im…
RT @CIR_AACR: Depleting #Tregs with an #ICOS-specific antibody increases #Tcell function, delays tumor growth, and improves efficacy of #Im…
RT @CIR_AACR: Depleting #Tregs with an #ICOS-specific antibody increases #Tcell function, delays tumor growth, and improves efficacy of #Im…
RT @CIR_AACR: Depleting #Tregs with an #ICOS-specific antibody increases #Tcell function, delays tumor growth, and improves efficacy of #Im…
Depleting #Tregs with an #ICOS-specific antibody increases #Tcell function, delays tumor growth, and improves efficacy of #ImmuneCheckpointBlockade. Learn more: @rcasainson @biomiha #KY1044 #PDL1 https://t.co/0CSMhCn7Tz https://t.co/TlnwscFK5E
RT @DrEzraCohen: ICOS targeting provides beneficial effects on both Tregs and CD8 effectors. Provides potential to improve on PD1/PDL1 inhi…
ICOS targeting provides beneficial effects on both Tregs and CD8 effectors. Provides potential to improve on PD1/PDL1 inhibition. https://t.co/yDvJ87WQje
RT @rcasainson: The final proof of our #KY1044 publication is now available online: "An Antibody Targeting #ICOS Increases Intratumoral Cyt…
The final proof of our #KY1044 publication is now available online: "An Antibody Targeting #ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression" https://t.co/Sv94bpJPvs #Tregs #Kymab
RT @Immune_News: 🔬 Scientists performed immune profiling of samples from tumor bearing mice and cancer patients to demonstrate differential…
RT @Immune_News: 🔬 Scientists performed immune profiling of samples from tumor bearing mice and cancer patients to demonstrate differential…
🔬 Scientists performed immune profiling of samples from tumor bearing mice and cancer patients to demonstrate differential expression of co-stimulatory receptor in immune T cell subsets in different tissues. #Treg @CIR_AACR 🔓 Open access https://t.co/gUzD